News | August 22, 2023
LEO Pharma to acquire Timber Pharmaceuticals
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Jeet will be a trusted partner in cardiovascular care
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The inspection closed with zero observations and a classification of No Action Indicated
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
